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Abstract
Progressive hearing loss is common in the human population, but we have few clues to the molecular basis. Mouse mutants
with progressive hearing loss offer valuable insights, and ENU (N-ethyl-N-nitrosourea) mutagenesis is a useful way of
generating models. We have characterised a new ENU-induced mouse mutant, Oblivion (allele symbol Obl), showing semi-
dominant inheritance of hearing impairment. Obl/+ mutants showed increasing hearing impairment from post-natal day
(P)20 to P90, and loss of auditory function was followed by a corresponding base to apex progression of hair cell
degeneration. Obl/Obl mutants were small, showed severe vestibular dysfunction by 2 weeks of age, and were completely
deaf from birth; sensory hair cells were completely degenerate in the basal turn of the cochlea, although hair cells appeared
normal in the apex. We mapped the mutation to Chromosome 6. Mutation analysis of Atp2b2 showed a missense mutation
(2630CRT) in exon 15, causing a serine to phenylalanine substitution (S877F) in transmembrane domain 6 of the PMCA2
pump, the resident Ca
2+ pump of hair cell stereocilia. Transmembrane domain mutations in these pumps generally are
believed to be incompatible with normal targeting of the protein to the plasma membrane. However, analyses of hair cells
in cultured utricular maculae of Obl/Obl mice and of the mutant Obl pump in model cells showed that the protein was
correctly targeted to the plasma membrane. Biochemical and biophysical characterisation showed that the pump had lost a
significant portion of its non-stimulated Ca
2+ exporting ability. These findings can explain the progressive loss of auditory
function, and indicate the limits in our ability to predict mechanism from sequence alone.
Citation: Spiden SL, Bortolozzi M, Di Leva F, de Angelis MH, Fuchs H, et al. (2008) The Novel Mouse Mutation Oblivion Inactivates the PMCA2 Pump and Causes
Progressive Hearing Loss. PLoS Genet 4(10): e1000238. doi:10.1371/journal.pgen.1000238
Editor: Wayne N. Frankel, The Jackson Laboratory, United States of America
Received February 28, 2008; Accepted September 25, 2008; Published October 31, 2008
Copyright:  2008 Spiden et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Medical Research Council, Wellcome Trust, Deafness Research UK, the EC (contracts CT97-2715, QLG2-CT-1999-00988,
and EUROHEAR LSHG-CT-20054-512063), the Telethon Foundation of Italy (Project GGP04169), and the Italian Ministry of University and Research (PRIN 2005, FIRB
2001).
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kps@sanger.ac.uk
. These authors contributed equally to this work.
" These four authors are joint senior authors on this work.
Introduction
PMCA2 is one of four isoforms of the plasma membrane Ca
2+
pumps of mammalian cells [1,2]. The expression of PMCA2 and
PMCA3 is largely restricted to brain and muscle, whereas PMCA1
and 4 are ubiquitously expressed. PMCA2 and PMCA3 are more
active in exporting Ca
2+ than the ubiquitous isoforms [3],
probably due to their higher affinity for the activator calmodulin.
PMCA2, however, is peculiar in its very high activity even in the
absence of calmodulin [4,5]. In the ear, PMCA2 is expressed at
high levels in outer hair cell stereocilia and apical membranes and
at moderate levels in inner hair cell stereocilia and in the spiral
ganglion [6–10]. It actively extrudes Ca
2+ that has entered the hair
cell during mechanoelectrical transduction [11]. This maintains
the low intracellular levels of Ca
2+ and may create a relatively
higher concentration of Ca
2+ in the endolymph surrounding the
stereocilia, contributing to the maintenance of the electrochemical
gradient needed for transduction to occur [11]. Bulk concentration
of Ca
2+ in mammalian cochlear endolymph is estimated at
,20 mM [12]. PMCA2 is also important in maintaining sufficient
extracellular Ca
2+ in the vestibular system for the formation of the
otoconia, the calcium carbonate crystals needed for sensing gravity
and acceleration [13].
Transcripts for PMCA2 undergo alternative splicing at two
sites. Site A is closer to the N-terminus and site C closer to the C-
terminus. In the PMCA2 variant expressed in stereocilia [14,15],
the splicing introduces three exons at site A, generating variant w,
and two alternative exons at site C, generating variant a. The C-
site insert leads to a truncated pump that contains only about half
of the original calmodulin binding domain [4,5]. The doubly
inserted w/a variant, seen in stereocilia, has an unusually limited
ability to increase activity rapidly when challenged with a Ca
2+
pulse, but has about the same high non-stimulated activity as the
full-length z/b variant [16].
PLoS Genetics | www.plosgenetics.org 1 October 2008 | Volume 4 | Issue 10 | e1000238The Oblivion (Obl) mutant was identified as a new mouse
mutant with progressive hearing loss from a large scale ENU
mutagenesis screen [17]. The aim of this screen is to provide new
models for deafness, especially progressive deafness which is
common in the human population, and to identify the genes and
underlying pathology in these new mutants. Here we report that
the progressive hearing loss in Obl is due to a missense mutation in
the gene Atp2b2, encoding PMCA2. We describe the hearing
impairment and hair cell pathology in the mutants, the
dysfunction of Ca
2+ export by the mutated PMCA2 pump cloned
and overexpressed in model cells and in cultures of utricles from
the mutant mice.
Results
Progressive Hearing Loss in Oblivion Mutants
Obl/+ heterozygotes have a normal Preyer reflex at one month
old, but by two months only 58% offspring from Obl/+6+/+
matings showed a Preyer reflex (Table S1), suggesting progressive
hearing loss in Obl/+ mice. No vestibular defect, indicated by
head-tossing or circling behaviour, was seen in these heterozy-
gotes, although no detailed analysis of vestibular function was
performed.
To measure auditory thresholds, auditory brainstem responses
(ABR), a reflection of cochlear and brainstem neural activity, were
recorded in P20, P59–62 and P89–91 mice on their original
C3HeB/FeJ genetic background (Figure 1). ABRs of wild-type
mice showed an improvement in thresholds below 12 kHz from
P20 to P59–62, perhaps indicative of maturation of the auditory
system. From P20 to P89–91, wild type mice showed mild and
progressive elevations of thresholds above 12 kHz.
Obl/+ mice demonstrated a severe and age-related progressive
hearing loss. Obl/+ mice showed significantly raised thresholds at
all frequencies, compared to age-matched wild-type controls (t-
test, p,0.05), of up to 60–70 dB or more. In contrast to the Preyer
reflex tests, even at P20 Obl/+ showed large threshold elevations.
At P59–62, the heterozygotes showed further threshold elevations
which were most severe at higher frequencies, above 18 kHz. By
P89–91, high frequency losses were compounded by severe losses
across the entire range measured. This indicated a progressive
hearing loss in Obl/+ mice. The improvement of low frequency (3–
6 kHz) ABR thresholds between P20 and P59–62 may indicate
maturation of the developing auditory system between these ages.
Obl/Obl homozygous mutants show a very severe hearing and
vestibular phenotype and are significantly smaller (10.5 g, SD
2.02) than age and sex matched Obl/+ littermates (17.3 g, SD
2.11; t-test, p,0.05, 31–34 days old). They (a) fail to develop a
Preyer reflex; (b) fall from side to side whilst walking; (c) are unable
to right themselves; and (d) curl towards their belly when lifted by
their tail and do not display a reaching response when lowered
towards a surface. Homozygotes also show hind limb stiffness and
appear ataxic, which are not general features of vestibular
dysfunction.
Structure of the Inner Ear
The gross morphology of the middle ear ossicles and inner ear
appeared normal in Oblivion mutants, both heterozygotes and
homozygotes. Scanning electron microscopy in Obl/+ mutants at
3–4 months of age showed degeneration of hair cells, with the
basal turn more severely affected than the apex, and outer hair
cells (OHCs) more affected than inner hair cells (IHCs), a pattern
that is commonly reported in damaged cochleas (Figures 2 and 3).
Figure 1. Auditory brainstem response thresholds in Oblivion
heterozygous and wildtype animals. Obl/+ mutants show signif-
icantly raised auditory brainstem response (ABR) thresholds compared
to wildtype mice at P20 (circles), P59–62 (squares), and P89–91
(triangles). Mean ABR thresholds with standard error bars are given
for +/+ mice (filled symbols) and Obl/+ mice (open symbols). The dotted
line without symbols indicates the maximum dB SPL output for the
sound system at each frequency. The position along the length of the
cochlear duct that best responds to each frequency (represented by %
of total distance from the base) is indicated by the frequency place map
at the top of the graph. Mean click ABR thresholds are plotted at an
arbitrary point on the frequency axis; the position does not relate to the
frequency content of the click stimulus.
doi:10.1371/journal.pgen.1000238.g001
Author Summary
Progressive hearing loss is very common in the human
population, but we know little about the causes.
Environmental and genetic factors each may contribute.
Knowledge of the genetic variants involved in hearing loss
and understanding of the molecular and cellular mecha-
nism of their action will aid the development of better
treatments. One of the few genes known to be involved, in
both mouse and humans, is Atp2b2, which encodes a
calcium pump. We have discovered a new mutation in this
gene leading to hearing loss in the mouse mutant
oblivion. The mutation leads to a serine to phenylalanine
substitution in a transmembrane domain. Mutations
affecting such transmembrane domains are usually ex-
pected to interfere with the normal process of inserting
the protein in the membrane and transporting it to its final
destination on the plasma membrane of the cell.
Surprisingly, the pump is produced and is targeted to
the plasma membrane, in both cultured cells expressing
the mutant gene and sensory hair cells from the oblivion
mutant inner ear. However, we show it has impaired
calcium pumping ability, which can account for the
progressive hearing loss as well as the progressive
degeneration of the sensory hair cells that we observe in
the mutants.
Novel PMCA2 Mutation and Hearing Loss in Mouse
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gotes. However, there were many remaining hair cells with
relatively normal appearance in the mutants, including a W-
shaped arrangement of stereocilia, especially in the apical turn.
Stereocilia fusion was seen in some, an early indicator of hair cell
degeneration. At P20, no significant hair cell loss was detected in
Obl/+ mutants compared to their littermate controls (Figure 3A
and 3B), despite the fact that we saw significantly raised ABR
thresholds in another cohort of P20 heterozygotes (Figure 1). Hair
cell counts from the basal and middle turns at P75 showed no
significant OHC degeneration in the middle turn and no
significant IHC loss throughout the cochlea in Obl/+ heterozy-
gotes (Figure 3C and 3D). By P121, there was significant OHC
and IHC loss in basal and middle turns in Obl/+ (Figure 3E and
3F). This suggests that the hair cell loss seen in these mutants is a
secondary consequence of the hair cell not functioning correctly,
rather than being the primary cause of raised thresholds in Obl/+
mutants.
In Obl/Obl mutants at P30 there was highly variable hair cell
degeneration, both within and between animals. In some regions
there was scattered hair cell loss with a pattern similar to that seen
in heterozygotes (Figure 2G and 2H), while in some regions
towards the base there was complete degeneration of the organ of
Corti with a complete absence of specialised cells, including
supporting cells such as pillar cells (Figure 2I).
Mapping and Identification of the Oblivion Mutation
Obl/+ mutants on a C3HeB/FeJ background were outcrossed to
C57BL/6J and mutant F1 progeny were backcrossed to the
original C3HeB/FeJ strain. Backcross litters were assessed for
absence of a Preyer reflex and a genome-wide scan was performed
on their DNA using 60 polymorphic microsatellite markers. We
identified a region of linkage on chromosome 6 (Figure 4A)
between markers D6Mit104 and D6Mit218, corresponding to a
physical distance of 16 Mb. This region contained a good
candidate gene: Atp2b2. Genomic DNA was used to sequence
the 19 coding exons of the gene, including the splice sites. We
identified a C/T heterozygous peak in Obl/+ mutants, suggesting a
CRT transition (2630CRT) in exon 15 of Atp2b2, predicted to
change a serine to a phenylalanine (S877F; Figure 4) in the mutant
allele. This change was also confirmed by a restriction test assay
that was used to genotype the colony. This assay was used to
screen 19 inbred strains for the Obl mutation and none were found
to have it, suggesting that it is not a common polymorphism. We
found non-complementation of Obl with the deafwaddler mutant
allele, Atp2b2
dfw, confirming that the missense mutation we found
was the pathogenic mutation (see Text S1).
Functional Analysis of the Mutated PMCA2 Pump
Overexpressed in Model Cells
To investigate the effectsof the serineto phenylalanine changeon
the functionality of the pump, mammalian expression plasmids for
the S877F and the wild type variant of the PMCA2 pump were
prepared and expressed in CHO cells. Appropriate controls
(Western blotting and quantitative immunocytochemistry) estab-
lished that the two pump variants were expressed at about the same
levels, and were correctly delivered to the plasma membrane
(Figure 5). CHO cells were transfected with the Ca
2+ sensitive
photoprotein aequorin (cytAEQ, [3]) and stimulated with ATP, an
agonist of purinergic P2Y receptors that produces InsP3 generating
a cytosolic Ca
2+ transient. Under the experimental conditions, the
height of the Ca
2+ peak, and the kinetics of the return of the Ca
2+
Figure 2. Analysis of wildtype, Obl/+, and Obl/Obl organ of Corti by scanning electron microscopy. At 3–4 months, normal animals show
three rows of outer hair cells (OHC) and one row of inner hair cells (IHC) in the apex (A), middle (B), and base (C) of the cochlea. Obl/+ have extensive
OHC loss and some IHC loss in the base of the cochlea (F) and a few missing OHC in the middle of the cochlea (E). The apex appears normal (D). At 1
month of age, the phenotype in the Obl/Obl mice is extremely variable. In some regions of the base, middle and apex, the phenotype is similar to that
seen in Obl/+. However, in other parts of the apex (G) and middle (H) regions of the cochlea, there are missing patches of OHCs. In some regions of
the base, there is a complete degeneration of the organ of Corti, with no IHC, OHC, or supporting cells such as pillar cells present (I). Scale
bar=10 mm.
doi:10.1371/journal.pgen.1000238.g002
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the much larger amounts of the overexpressed PMCA2 pump
overshadowed the endoplasmic reticulum Ca
2+ pump (SERCA) (see
[16]) and the contribution of plasma membrane Ca
2+ influx
channels opened by emptying of intracellular stores to the shaping
of the Ca
2+ trace was disregarded, as their effect would be the same
in the wild type and Obl measurements. The overexpressed Obl
pump did not further depress the limited ability of the wild type w/a
pump to control the height of the Ca
2+ peak (Figure 6). The
mutation,however, severelyaffectedtherestingactivity ofthepump
that drove the return of the Ca
2+ trace to baseline after the peak.
The half time of the declining phase was 64.1563.02 sec (n=6) in
control, 6.5560.72 sec (n=9) in the wild type w/a variant and
45.5065.97 sec (n=4), p,0.001, in Obl.
Ca
2+ Dynamics in the Hair Cell Stereocilia of Wild Type,
Obl/+, and Obl/Obl Mice
To characterize Ca
2+ dynamics in the stereocilia of hair cells,
cultures of immature utricular maculae were obtained from wild
type and mutant mice (see Materials and Methods). Ca
2+-
dependent changes in fluorescence evoked by the photorelease
of intracellular caged Ca
2+ (4 ns single UV pulse) were monitored
with a temporal resolution of 6 ms using confocal laser scanning
microscopy. Immunofluorescence labelling with isoform specific
antibodies showed that PMCA2 was correctly located in the
stereocilia of homozygous mutant organotypic cultures of utricular
maculae (Figure 7A) and organ of Corti (Figure 8). Figure 7B
shows a macular hair cell loaded with Fluo-4. Fluorescence
changes in the stereocilia were monitored repeatedly by a line-scan
positioned along the hair bundle and extending into the cell soma
(dashed line). Time-dependent post UV pulse changes in
fluorescence at different parts of the line scan are illustrated in
Figure 7C. The time course of the stimulus-evoked changes in
fluorescence (DF), normalized to basal (pre-stimulus) fluorescence
(F0), are compared for wild type (wt, blue trace) heterozygous
Oblivion mice (Obl/+, green trace) and homozygous Oblivion
mice (Obl/Obl, black trace) in Figure 7D. The time courses
matched well at the peak, although the [Ca
2+]i transient decayed
more slowly for the Obl/Obl mice. To highlight the differences, the
traces are re-plotted in Figure 7E on an expanded time scale (solid
lines), together with their respective confidence intervals (dash-
dotted lines). A single exponential fit to the first 10 s of these
transients yielded significantly longer decay time constants for the
Obl/+ and Obl/Obl cultures: twt=2.860.4 s for wt, tObl/+
=4.261 s for Obl/+ mice (p=0.02, if compared to wt using the
ANOVA test) and tObl/Obl=6.961.3 s for Obl/Obl mice (p,0.01).
No significant divergence in the early phase (first 2 s) of the decay
was found for Obl/+ mice relative to wt, consistent with the lack of
evident phenotypic vestibular defects in these mice. At later times,
the decay tended to diverge possibly due to the contribution of
complex processes such as Ca
2+-induced Ca
2+ release. These
contributions were not investigated further.
Discussion
Progressive, age-related hearing loss affects 60% of humans over
the age of 70 [18]. The condition is a multifactorial disorder to
which genetic variation, disease and environmental influences such
as acoustic trauma are all contributing factors, making identifica-
tion of the genes involved in humans difficult. The mouse is an
ideal resource to study the genetics of progressive hearing loss due
Figure 3. Hair cell counts in Oblivion heterozygous and wildtype animals. Hair cell counts show that outer hair cell loss in heterozygotes
(Obl/+) at P75 is present in the base (C) but not the middle (D) of the cochlea. By P121, outer hair cell loss is seen in the base (E) and the middle (F) of
the cochlear duct. IHC loss is seen in the base of the cochlea only at later ages (E). This suggests that hair cell loss in Obl/+ mutants progresses in a
base to apex direction, with OHC loss occurring first and IHC loss later. No OHC or IHC loss was seen in the base (A) or middle (B) regions of the
cochlea at P20. Hair cell counts calculated as mean number of hair cells per 100 mm at P20 (+/+ n=4–7, Obl/+ n=7), P72–75 (+/+ n=4,Obl/+ n=5)
and P121 (+/+ n=3–4, Obl/+ n=4–5). Error bars indicate 95% confidence interval, T-test, * P-value,0.05.
doi:10.1371/journal.pgen.1000238.g003
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environment.
The present study has identified a new ENU-induced allele of
Atp2b2, Atp2b2
Obl in the Obl mouse mutant. This allele contains a C
to T missense mutation in exon 15 of Atp2b2, causing a non-
conservative amino acid substitution of serine by phenylalanine in
transmembrane domain 6 of the PMCA2 pump [1,19]. The serine
at position 877 is highly conserved in both human and mouse and
also between other members of the PMCA family (Figures 4C and
S2). The S877F mutation is of special interest on at least two
accounts. One is the finding that substitutions in the transmem-
brane residues of the PMCA pump frequently impair its correct
plasma membrane targeting [20]. However, the mutant Obl pump
was correctly delivered to the plasma membrane in both the model
cells and in native stereocilia. In another Atp2b2 mutant allele,
Wriggle mouse Sagami (wri), a missense mutation in transmem-
brane domain 4 completely abolished the expression of PMCA2
protein in stereocilia of cochlear hair cells [21]. The second reason
for interest stems from studies of the SERCA pump of
endoplasmic reticulum, considered a model for all P-type pumps.
Conserved residues within transmembrane domain 6 of SERCA
have been shown to be components of the channel through which
Ca
2+ is translocated [22] and are also present in the PMCA pump.
It is pertinent to quote at this point an earlier study on some point
mutations in transmembrane domain 6 of another isoform of the
pump, PMCA4 [23]. In that study, one of the mutants (S877A)
appears to have higher activity than the wild type pump. The
reason for the different effect of the S877A mutation of PMCA4
and the S877F mutation of PMCA2 that we report here is not
clear. However, the PMCA4 study is difficult to compare with the
present one, since it analyzed the pump in crude microsomes of
overexpressing COS cells, and offered no information on the
localization of the expressed pump in the plasma membrane.
The Obl mutation is the seventh mutation in mouse Atp2b2 to be
reported. In the deafwaddler (dfw) mouse a missense mutation in
Atp2b2 leads to a partial loss of function [8] and PMCA2 retains
30% of its Ca
2+ pumping activity [24]. A spontaneous T692K
mutation in Atp2b2 led to clear ataxic behaviour, with normal
mRNA levels, in a second unnamed mutant [25]. A further four
mutations of mouse Atp2b2 have been described: deafwaddler 2J
(dfw
2J), deafwaddler 3J (dfw
3J), wriggle mouse sagami (wri) and a
targeted null mutation. Analysis of mRNA transcripts and protein
levels suggests that these latter four mutations are all null alleles
[13,21,26]. Homozygotes for these alleles show severe ataxia by 10
days of age as well as profound deafness. The profound deafness
and ataxia detected in Obl homozygotes is similar to the phenotype
of these other known Atp2b2 null mutants [13,26,27]. Non-
complementation between Obl and dfw confirmed that these two
mouse mutants are likely to be allelic. The mutations identified in
the Atp2b2 gene are shown in Figure S1.
Both the Obl and the dfw mutations significantly reduce the non-
activated Ca
2+ exporting ability of the PMCA2 protein. Obser-
vations on organotypic cultures showed that the defect of the
pump observed in model cells also reduced its ability to remove the
Ca
2+ produced by UV photolysis in stereocilia. Thus, the Obl
mutant has lost a significant portion of the non stimulated, longer-
term Ca
2+ exporting ability in respect to the w/a PMCA2 pump.
In the present work we show that hearing loss in Obl/+ mice is
detected at P20 and progresses in its severity with increasing age.
Threshold shifts of up to 60-70 dB were found at frequencies
corresponding to the basal and middle turns of the cochlea, where
the majority of outer hair cell loss was detected. Analysis of Obl/+
mice at P20 showed no OHC or IHC loss despite the fact that they
had a significant hearing impairment, confirming the previous
suggestion that although hair cells are present they are not
functioning normally [28].
IHC loss was detected in the base and middle of the cochlea in
Obl/+ mutants at 4 months of age. The early degeneration of the
OHCs seen in heterozygous Obl (and dfw) mice, leading to
complete degeneration of the organ of Corti in the base of the
cochlea, is similar to that seen in some human patients with age-
related hearing loss [29,30]. It is not clear why hair cell
dysfunction leads to hair cell degeneration in these mouse
mutants, but prolonged abnormal calcium homeostasis may
contribute to hair cell death. In dfw mice at approximately P60,
distortion product otoacoustic emission studies show that PMCA2
is important for the correct functioning of outer hair cells,
especially at high frequencies [31]. Mice expressing the Atp2b2
dfw2J
allele, [9] demonstrated a lowered endocochlear potential and
reduced endolymphatic calcium concentration, and thus have a
reduced capacity for mechanoelectrical transduction. Taken
together, these features may explain why ABR thresholds in
Figure 4. Oblivion chromosomal location, mutation, and PMCA2
sequence alignment. (A) Obl mutation maps to a 16 Mb region on
mouse Chromosome 6, between D6Mit104 and D6Mit218. Each box
represents a marker typed, and each chromosomal arrangement
detected is shown, with the number of animals possessing that
chromosome given underneath. If a marker was not typed, then no box
is present. (B) Sequence of Atp2b2 in Obl/+ mouse showing the CRT
mutation and predicted sequence. (C) Sequence alignment of several
PMCA family members showing Ser877 is highly conserved.
doi:10.1371/journal.pgen.1000238.g004
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An interesting observation from the ABRs recorded in P59–62 and
P89–91 Obl/+ mice is that click thresholds are more sensitive than
the best tone threshold, by a factor of 15–22 dB. Clicks produce a
more synchronised activation of a wider region of the basilar
membrane compared to tone pips, and this may produce a
summation of activity, reflected in lower click-evoked ABR
thresholds.
When Obl was placed on a mixed C3HeJ/FeB and C57BL/6J
background, the progressive hearing loss in heterozygotes seemed
more severe (data not shown). Onset and severity of progressive
hearing loss seen in heterozygotes of other Atp2b2 mutant alleles
have been shown to vary considerably depending on the genetic
background on which the mutation arose [13,21,26,28,32]. This is
due to the presence of modifier alleles, one of which has been
identified as the G753A variant of Cdh23 at the ahl locus (also
known as modifier of deafwaddler, mdfw) [32,33]. Interactions
between heterozygous Atp2b2 mutations and Cdh23 mutations
have been shown to worsen the progressive hearing loss seen in
some human patients. Heterozygous mutations (ATP2B2
V586M)
increase the severity of the progressive hearing loss seen in human
patients with mutations in CDH23 [34]. The ATP2B2
V586M
mutation reduced the level of PMCA2 protein produced by
50%, although on its own it was not sufficient to cause hearing
impairment in humans [34]. More recently, hearing loss has been
reported in a human patient with an ATP2B2
G293S mutation and a
CDH23
T1999S mutation. The parents of the patient carried either
the ATP2B2 or the CDH23 mutation, but had no hearing
impairment [16].
The ATP2B2 gene has recently been implicated in the deafness
in 3p- syndrome. The syndrome is characterised by developmental
delay, growth retardation and craniofacial abnormalities (see [35]),
which is sometimes, but not always, associated with a severe
sensorineural hearing loss. In 3p- syndrome patients with a
hearing loss, a deletion in the 3p25.3 locus was mapped to a region
containing 18 genes including ATP2B2. It is likely that
haploinsufficiency of ATP2B2 is responsible for the deafness
associated with this syndrome [36].
As progressive hearing loss is so common in the human
population and we know so little about its molecular basis,
identifying other mutations in and modifiers of the Atp2b2 locus in
mouse inbred strains may be of importance in identifying new loci
involved in progressive and age-related hearing loss in humans.
Materials and Methods
Mice
The founder mouse carrying the Oblivion mutation (gene
symbol Obl, original identifier DEA14) arose from the ENU
mutagenesis program at Munich [17]. Mutations were generated
by injecting 3 doses of 80–90 mg/kg bodyweight of N-ethyl-N-
nitrosourea (ENU) into C3HeB/FeJ males. F1 progeny were
screened for a range of phenotypes, including deafness and
balance disorders. The founder Obl/+ mutant was identified by the
absence of a Preyer reflex at 3 months. The mutant colony was
maintained on the C3HeB/FeJ background, and all ABR and
Figure 5. Expression and immunolocalization of recombinant
PMCA2 pumps in CHO cells. (A) Western blotting analysis. Upper
panel, 48 h after transfection CHO cells were washed twice with cold
PBS buffer and scraped in lysis buffer (Tris-HCl 10 mM, EDTA 1 mM,
PMSF 2 mM and DTT 1 mM). After centrifugation at 10006g for 5 min,
the cells were resuspended in 80 ml of lysis buffer and subjected to
three cycles of freeze and thaw. The proteins of the lysates were
quantified using the Bradford Reagent (Sigma-Aldrich). 15 mgo f
proteins were loaded on 10% polyacrylamide gel and transferred to
nitrocellulose membranes which were incubated with polyclonal
PMCA2 antibody 2N and monoclonal b-actin antibody (Sigma-Aldrich).
After incubation with HRP-conjugated secondary antibodies (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), the blots were developed with ECL
reagents (Amersham Life Science). The band of ,130 kDa corresponds
to PMCA2 and the band of ,42 kDa to b-actin. Lower panel, the
relative expression of wt and Obl PMCA2 was determined by scanning
the immunoblots digitally with Kodak 1D Image Analysis Software. The
amount of Ca
2+ pump protein was normalized for b-actin and the
quantity of proteins was compared. (B) Immunolocalization of wt and
Obl PMCA2 in transiently transfected CHO cells. The interaction with 2N
antibody was revealed by the AlexaFluor488-conjugated secondary
antibody. Upper panel, plasma membrane pattern of the overexpressed
pumps (details in Materials and Methods). (a) wild type w/a pump. (b)
Obl/Obl pump. Lower panel, fluorescence level in the plasma
membrane quantified as described in Material and Methods. The SDs
are indicated by the bars.
doi:10.1371/journal.pgen.1000238.g005
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care and use of animals was carried out in accordance with UK
Home Office regulations and the Animal Care and Use
Committee of the University of Padua.
Inner Ear Clearing and Ossicle Dissection
Half heads were fixed in Bodian’s fixative and cleared with
glycerol using a standard protocol. The inner ear was examined
for signs of malformation. Middle ear ossicles were dissected out
and studied. Six Obl/+ mutants and six littermate controls between
3–4 months age were analysed.
Scanning Electron Microscopy
Inner ears were fixed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer, the organ of Corti was exposed and samples
were processed using the osmium tetroxide-thiocarbohydrazide
(OTOTO) method [37]. After critical point drying and sputter
coating with gold, samples were examined using a Phillips XL30
scanning electron microscope at 10 kV or a Hitachi S4800 FE
Scanning Electron Microscope at 5 kV. Initial characterisation
was performed on 3 Obl/+ and 3 littermate controls at 3–4 months
of age. Hair cell degeneration was assessed in the basal turn (20–
30% of the total distance from the base of the cochlear duct) and
Figure 6. Activity of recombinant PMCA2 pumps in CHO cells. Cells were transiently co-transfected with the PMCA2 variants and cytAEQ, or
only with cytAEQ (control). They were then perfused with KRB supplemented with 1 mM CaCl2. 100 mM ATP was used to produce a transient Ca
2+
increase (A). The histograms in (B) and (C) show the means6SD of Ca
2+ peaks and the half peak decay times, respectively (n indicates the number of
experiments considered for the statistical analysis), * p,0.01 calculated with respect to the wt pump.
doi:10.1371/journal.pgen.1000238.g006
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days old. Between 3 and 7 Obl/+ and +/+ mice were examined at
each age. Hair cells with intact stereocilia bundles were counted
over a stretch of at least 200–300 mm of the cochlear duct. Hair
bundles that were damaged or showed fusion were still counted as
being present. A two tailed T-Test was performed on hair cell
counts for each hair cell row in each region at 95% confidence
intervals, with the number of cases and standard deviations
included in the analysis. A two tailed T-test was carried out on the
weights of Obl/Obl mutants compared to littermate (Obl/+)
controls in the same way.
Preyer Reflex and Auditory Brainstem Response (ABR)
The Preyer reflex (pinna flick) was detected using a custom-built
click box to deliver a calibrated 20 kHz sound burst at 90 dB SPL.
Up to 88 mice from Obl/+6+/+ matings were tested weekly from
3 to 8 weeks of age, although the numbers of mice at each time-
point varied. For ABR recordings, a separate cohort of mice were
Figure 7. Dissipation of Ca
2+ transients in utricular hair cells co-loaded with Fluo-4 and caged Ca
2+. (A) Immunolocalization of the
PMCA2 pump in the stereocilia of Obl/Obl utricular hair cells (details in Materials and Methods). Localisation in wildtype hair cells appears identical to
that of mutants. (B) Confocal image of baseline Fluo-4 fluorescence in an organotypic culture of mouse utricular macula. The diagonal dashed line
represents the scan line during subsequent data acquisition. The hair bundle comprises the top and middle horizontal dotted lines (the latter crosses
the cell cuticular plate). The cell soma comprises middle and lower lines. (C) In this line-scan image, ordinates are pixel positions along the scan line,
abscissa is time and fluorescence transients, DF/F0, evoked by a 4 ns UV pulse (arrow), are color-coded according to the color scale-bar at right.
Signals from pixels below the lowermost horizontal dotted line arise from the cell adjacent to the hair cell in (B). (D) Fluorescence traces obtained by
spatially averaging line-scan pixel signals within the stereociliary compartment of wild type (wt, blue solid line), heterozygous (Obl/+, green solid line),
and homozygous Oblivion mice (Obl/Obl, black solid line). Each trace is the population average of n=6 cells (for wt and Obl/Obl) or n=5 cells (for
Obl/+). The region within the dash-dotted box is shown on a faster time scale in (E). Also shown in (E) are confidence intervals (dash-dotted lines) for
the average DF/F0 responses (solid lines).
doi:10.1371/journal.pgen.1000238.g007
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trodes inserted on the vertex (active), and over the left (reference)
and right (ground) bullae. A calibrated sound system was used to
deliver free-field click (0.01 ms duration) and tone pip (various
frequencies from 3–42 kHz of 5 ms duration, 1 ms rise/fall time)
stimuli at a range of intensity levels in 3 dB (or multiple) steps.
Averaged responses to 512 stimuli, presented at 21.1 s
21, were
analysed and thresholds established as the lowest sound intensity
giving a visually-detectable ABR response. ABR recordings were
obtained from a total of 61 mice, 28 at P20 (+/+,n = 9 ;Obl/+,
n=19), 14 at P59–62 (+/+,n=5 ;Obl/+, n=9) and 19 at P89–91
(+/+,n=5 ;Obl/+, n=14).
Mapping the Obl Mutation
Obl/+ mutants on a C3HeB/FeJ background were outcrossed to
C57BL/6J wild type females. Obl/+ F1 progeny were then
backcrossed to +/+ animals from the original C3HeB/FeJ strain.
Offspring from these backcross matings were examined at 2
months of age or older (as this is the age at which Obl/+ mice on
the original genetic background show profound hearing loss) using
the Preyer reflex. Tail and pinna tissue were collected for DNA
preparation. A total of 255 backcross mice were analysed (129
Obl/+, 126 +/+). A genome-wide scan was conducted with 60
microsatellite markers approximately 25 cM apart, that had been
shown to be polymorphic between C3HeB/FeJ and C57BL/6J
inbred strains (Table S2). Additional microsatellite markers used
for fine mapping of the Obl mutation were: D6Mit36; D6Mit104;
D6Mit150; D6Mit115; D6Mit218; D6Mit254. PCR was performed
using standard techniques.
Mutation Screening and Confirmation
Sequence analysis was performed on genomic DNA in Obl/+
mutants and littermate controls using primers designed to amplify
the coding exons and splice sites of the Atp2b2 gene. The primer
sequences are listed in Table S3. PCR was performed using
standard techniques and products were cleaned using magnetic
bead separation (Ampure) and sequenced using BigDye Termi-
nator Cycle sequencing kit (Applied Biosystems). Sequence traces
were analysed using Gap4 software [38]. To confirm the mutation
identified in exon 15 and for genotyping of the colony, a PCR-
based genotype test was designed. The 2630CRT missense
mutation did not change a restriction enzyme recognition site, so
primers were designed flanking the mutation site that would
incorporate a StyI recognition site in the wildtype (C) allele, but not
in the mutant (T) allele. Primers OblRTF (59-CTT CTT CTC
CCT GCC ACT GTC GTA G) and OblRTR (59-CCA CCG
AGA CAC CGG TCC CGG TTC) were used for PCR. The
111 bp PCR product was digested with StyI (New England
Biolabs) which cuts the wildtype allele giving an 89 bp fragment
while the mutant allele remains uncut. This genotyping tool was
used to establish whether the sequence change in Obl DNA was a
polymorphism in a total of 17 inbred strains: BALB/C, CBA/Ca,
C3HeB/FeJ, DDY/Jc1, 129X1/SvJ, A/J, Bxd-1/Ty, C58/J, CE/
J, DA/HuSn, DBA/2J, FL/1Re, LP/J, NON/LtJ, RBG/Dn, St/
bJ and SWR/J.
Cloning and Mutagenesis of pmRFP-PMCA2 w/a
mRFP was amplified from pCDNA3.1/zeo-mRFP (kindly
donated by Dr. M. Zaccolo, Padua, Italy) using the following
primers, forward: 59-GCGCTAGCATGGCCTCCTCCGAG-
GACGTCA-39 and reverse: 59-GCAGATCTGAGGCGCC-
GGTGGAGTGGCGG-39, bearing restriction sites for NheI and
BglII, respectively (in bold). The PCRproduct was then digested with
NheI and BglII and inserted in pEGFP-c1 (Clontech, Palo Alto, CA)
digested with NheI and BglII to create pmRFP-c1. PMCA2 w/a in
pMM2(kindlyprovided by Dr.Strehler,Rochester,MN)was excised
Figure 8. Immunolocalisation of PMCA2 in cochlear hair cells. Confocal imaging immunoassays of PMCA2 (green) in cochlear whole mounts
from wild type (+/+), heterozygous (Obl/+), and homozygous (Obl/Obl) mice (red, actin). For details, see Materials and Methods.
doi:10.1371/journal.pgen.1000238.g008
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inserted into XhoI-KpnI sites of pmRFP-c1 in a three-part ligation
reaction resulting in pmRFP-PMCA2wa. The construct was
controlled by sequencing. Site-directed mutagenesis was carried out
to obtain the mutant cloned in the appropriate vector. pmRFP-
PMCA2w/a was used as target and experiments were performed
according to the manufacturer’s standard protocol (Stratagene,
Cedar Creek, TX) The following primers were used: Obl 59
CATCATGGACACATTTGCTTTCCTGGCCCTGGCAACA-
GAGC 39 (forward) and 59 GCTCTGTTGCCAGGGCCAG-
GAAAGCAAATGTGTCCATGATG 39 (reverse)
Immunolocalization of the Expressed Pumps and
Membrane Fluorescence Computation
CHO cells were grown in Ham’s F12 medium, supplemented
with 10% fetal calf serum (FCS). Before transfection, they were
seeded onto 13 mm glass coverslips and allowed to grow to 50%
confluence. Transfection with 3 mg of plasmid DNA (or 1.5
:1.5 mg in the case of co-transfection) was carried out with a Ca-
phosphate procedure [39]. Immunocytochemistry quantified the
expressed pump proteins in the plasma membrane of transfected
cells. CHO cells expressing the PMCA2 variants, were stained
with polyclonal isoform-specific PMCA antibody 2N (Affinity
Bioreagent, Inc., Golden, CO) or a monoclonal antibody
recognizing all pump isoforms (5F10, Affinity Bioreagent, Inc.,
Golden, CO), at a 1:100 dilution in PBS. Staining was carried out
with Alexa 488 labelled anti-rabbit or anti-mouse secondary
antibodies (Molecular Probes, Invitrogen Corp., Carlsbad, CA) at
a 1:50 dilution in PBS. Cells were imaged on a spinning disk
confocal microscope (Ultraview; Perkin-Elmer) by using a X60 oil-
immersion objective at a N.A. (PlanAPo; Nikon, Tokyo, Japan).
Regions of interest were selected by applying an edge-finding
(Sobel) digital filter, thus limiting the analysis to plasma membrane
areas. The total fluorescence intensity in membrane-delimiting
regions of interest was quantified with software developed in our
laboratory. For each construct fluorescence was averaged over a
total of 50 cells in 3 different slides.
Ca
2+ Measurements with Recombinant Aequorin
Transfected cytAEQ were reconstituted by incubating CHO
cells for 1–3 h with 5 mM coelenterazine in Dulbecco’s modified
Eagle’s medium (D-MEM) supplemented with 1% FCS, at 37uC
in a 5% CO2 atmosphere. Additions to the KRB medium (1 mM
CaCl2, 100 mM ATP) were made as specified in the figure legends.
The experiments and luminescence calibration into [Ca
2+] values
were carried out according to [40]. The experiments were
terminated by lysing the cells with 100 mM digitonin in a
hypotonic Ca
2+-rich solution (10 mM CaCl2 in H2O) to discharge
the remaining aequorin pool. Briefly, a 13-mm round coverslip
with the transfected cells was placed in a perfused thermostated
chamber in close proximity to a low-noise photomultiplier, with a
built-in amplifier discriminator. The output of the discriminator
was captured by a Thorn-EMI photon-counting board and stored
in an IBM-compatible computer for further analyses. Lumines-
cence was calibrated off-line into [Ca
2+] values by using a
computer algorithm based on the Ca
2+ response curve of wt
aequorin. Data are reported as mean6SD. Statistical differences
were evaluated by Student’s 2-tailed t-test for unpaired samples. A
p value,0.01 was considered statistically significant.
Preparation of Organotypic Utricle Cultures
To access utricular maculae of wild type or mutant mice
between postnatal day 3 (P3) and P4, the otic capsule was opened
medially and the endolymphatic compartment of the macula cut
open. The otolithic membrane was removed after 15 min
incubation in dissection saline to which 0.1 g/l bacterial subtilisin
(type XXIV; Sigma-Aldrich, St. Louis, MO) had been added.
Dissection saline was composed of Hank’s Balanced Salt Solution
(HBSS; part number H6648, Sigma-Aldrich) with 10 mM
HEPES, 10.000 U/l penicillin and 25 mg/l fungizone. HBSS
contained (in g/l): 0.4 KCl, 0.06 KH2PO4 (anhydrous), 0.35
NaHCO3, 8.0 NaCl, 0.048 Na2HPO4 (anhydrous), 1 D-glucose.
The epithelium was fixed by Cell-Tak (BD Biosciences, Bedford,
MA), mixed with 90% NaHCO3, to the lateral side of a glass
capillary (1.5 mm diameter, 5 mm length), which had been
previously glued to a microscope slide by a small drop of Sylgard
Silicon Elastomer (Dow Corning, Wiesbaden, Germany). Cultures
were preserved for one day at 37uC in a complete medium of 95%
D-MEM/Ham’s F-12 (1:1) (concentration 1X, liquid form,
containing L-glutamine but no HEPES; Gibco, Invitrogen Corp.,
Carlsbad, CA) and 5% fetal bovine serum.
Immunolocalization of PMCA2 in the Stereocilia of Hair
Cells in Utricle Cultures
Organotypic cultures dissected from P3 wild type and mutant
mice pups were maintained over night at 37uC in D-MEM/Ham’s
F-12 (1:1) medium with 5% fetal bovine serum. Tissue preparations
were fixed in paraformaldehyde 4% for 20 min at room
temperature, rinsed in washing solution (PBS containing BSA 2%)
and permeabilised with washing solution containing Triton 0.1%
for 1 h at room temperature. Incubation with primary PMCA
antibody 2N was carried out overnight at 4uC using a 1:100 dilution
in washing solution. FITC-conjugated rabbit anti-IgG antibody
(Invitrogen) was used as secondary antibody for pump detection
(1:200 dilution in washing solution, 2 h at room temperature). The
preparation was mounted on a coverslip and imaged up side down
on an inverted spinning disk confocal microscope (Ultraview;
Perkin-Elmner) using a 606oil-immersion objective at a 1.4 N.A.
(PlanApo; Nikon, Tokyo, Japan).
Whole Cochlea Immunohistochemistry
Cochleae dissected from P5 mice were fixed in 4% parafor-
maldehyde for 20 min at room temperature, rinsed in PBS
containing 2% BSA (rinse solution) and permeabilized for 1 hour
at room temperature with 0.1% Triton, dissolved in rinse solution.
Tissues were stained with polyclonal isoform-specific PMCA
antibody 2N (Affinity Bioreagent, Inc., Golden, CO) by incubation
overnight at 4uC with specific polyclonal antibodies (2.5 mg/ml)
(Invitrogen) diluted in rinse solution. A FITC conjugated rabbit
anti–IgG antibody (5 mg/ml, Invitrogen) was used as secondary
antibody, following incubation in rinse solution for 2 hours at
room temperature. F–Actin was stained by incubation for 1 hour
at room temperature with rhodamine phalloidin (7 mM, Invitro-
gen, R415) diluted in rinse solution. Stained samples were
sandwiched between two coverslips and imaged with a 606 oil–
immersion objective (NA 1.4, Plan Apo, Nikon, Tokyo, Japan)
attached to an inverted microscope (Eclipse 200, Nikon) equipped
with a Nipkow disk confocal scanning head (Ultraview, Perkin
Elmner, USA). Confocal fluorescence images were captured with a
scientific grade cooled CCD camera (Orca, Hamamatsu Photon-
ics, Hamamatzu City, Shizuoka, Japan).
Confocal Imaging of Organotypic Utricle Cultures
Cultures were loaded with 10 mM cell permeant Fluo-4 AM
(Invitrogen) for 50 min at 37uC in D-MEM supplemented with
10 mM cell permeant NP-EGTA AM (Invitrogen), 25 mM
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tion, cultures were transferred to an experimental chamber
mounted on the stage of a confocal imaging setup (Biorad
Radiance 2100) incorporating an upright microscope (Eclipse
E600FN, Nikon, Tokyo, Japan) and superfused for 20 min with a
medium composed of HBSS supplemented with 4.4 g/l glucose
and 2 mM anhydrous CaCl2 (pH 7.4, Osm 330). Experiments
were performed with a 1006 water-immersion objective (N.A.
1.00, LUMPlanFl, Olympus, Tokyo, Japan) using the same
perfusion medium. Fluo-4 fluorescence was excited by the
488 nm line of an argon laser coupled by fiber optics to the
confocal microscope. Fluorescence emission was selected around
528 nm using a narrow-band (50 nm) interference filter. Fluores-
cence images of utricle hair cells in the organotypic cultures were
acquired with a resolution of 5126512 pixel by scanning at 512
lines per second under control of the Biorad Laser Sharp software.
To be retained for subsequent recording, imaged cells had hair
bundles extending for their entire length in a single confocal plane
(bundle planarity condition), a possibility afforded by having the
culture attached to a curved surface.
Confocal Line-Scan Recording and UV Photolysis of
Caged Ca
2+ in Utricular Hair Cells
Dynamic fluorescence data were acquired in the ‘linescan’ mode
toproducea scanseriesoffluorescenceintensityvalues,F,measured
in the photomultiplier tube PMT units from a value of 0 to a
saturatingvalueof255.LaserintensityandPMTgainwereadjusted
to accommodate the dynamic range of changes in F. Typical
background fluorescence values, measured from regions devoid of
obvious cellular structures, were ,1 PMT units, while pre-stimulus
(basal) levels, F0, averaged over the entire length of the hair bundle,
were ,8 PMT units. In all experiments pinhole aperture was
adjusted to the same value, yielding confocal section with 3 mm
thickness. To assay the Ca
2+ extrusion activity of the PMCAs, an
area of ,3000 mm
2, comprising a few hair cells in the cultured
utricular macula, was exposed to UV radiation generated by an air-
cooled 337 nm pulsed nitrogen laser (Model VSL-337ND-S,
Spectra Physics, Mountain View, CA, USA) connected to the
microscope through a 600 mm optical fiber. UV light was directed
onto the sample by reflection off a 400 DCLP dichromatic beam
splitter (Chroma) positioned at 45u just above the microscope
objective lens. A single laser pulse (4 ns) delivering a maximum of
326 mJ of energy (at the laser output) was used to photorelease Ca
2
from the caged state (NP-EGTA bound to Ca
2+) in the brief time
interval between the 2500
th and the 2501
st scan line. In a typical
record lasting about 120 s, 20 000 consecutive lines were acquired.
Off-Line Analysis of Fluorescence Transients
All data were analyzed offline on a personal computer using the
Matlab 7.0 (The MathWorks, Inc., Natick, MA) software
environment. Data are presented as DF/F0 where DF=F2F0.I n
these expressions, raw pixel values are spatial averages along the
hair bundle. Maximal percent fluorescence changes, (Fmax2F0)/F0,
wereabout 280%.To estimate the slowtime constant,t,ofrecovery
to baseline, transients peaking at DFmax, were fitted by a single
exponential function during the first 10 s from the UV pulse. Data
are given as mean6standard error of the mean (S.E.M.).
Supplementary materials.
Figure S1 Mutations identified to date affecting PMCA2 protein
in mice. Three mutations are missense mutations leading to amino
acid substitutions (dfw, wri, Obl), two are small deletions that lead to
frame shift mutations and premature truncation of the PMCA2
protein (dfw
2J, dfw
3J), and one is a targeted null allele (Atp2b2
tm1Ges)
[8,13,21,26]. Adapted from [21].
Found at: doi:10.1371/journal.pgen.1000238.s001 (0.29 MB TIF)
Figure S2 Amino acid alignments of PMCA isoforms. Align-
ment of the amino acids residues in transmembrane domain 6 of
PMCA isoforms in different species (A) and of PMCAs and other
P-type ATPases (B). The similarity analysis was performed using
the ClustalW program. GenBank accession numbers are listed:
NP_001674 (Homo sapiens), Q9ROK7 (Mus musculus), NP_036640
(Rattus norvegicus), XP_509257 (Pan troglodytes), NP_777121 (Bos
taurus), NP_999517 (Sus scrofa), Q00804 (Oryctolagus cuniculus),
AAK11272 (Rana catesbeiana), AAH77905 (Xenopus laevis),
AAR28532 (Procambarus clarkii), AAR13013 (Stylophora pistillata),
AAK68551 (Caenorhabditis elegans), XP_653525 (Entamoeba histoly-
tica), AAP46286 (Trypanosoma brucei), EAL62716 (Dictyostelium
discoideum), NP_849716 (Arabidopsis thaliana), AAB81284 (Paramecium
tetraurelia), NP_001001323 (PMCA1), NP_068768 (PMCA3),
NP_001675 (PMCA4), NP_004311 (SERCA1), NP_733765
(SERCA2), NP_777615 (SERCA3), AAF35375 (SPCA1),
NP_000693 (Na
+/K
+ ATPase), and AAH31609 (Na
+/K
+
ATPase).
Found at: doi:10.1371/journal.pgen.1000238.s002 (1.73 MB TIF)
Table S1 Progressive hearing loss in litters from Obl/+6+/+
matings. Progressive hearing loss detected in Obl/+ mutants starts
at 1 month of age (6%), with most being deaf by 2 months of age
(42%). 50% offspring from Obl/+6+/+ mating are expected to
show phenotype.
Found at: doi:10.1371/journal.pgen.1000238.s003 (0.04 MB DOC)
Table S2 Microsatellite markers polymorphic between C3HeB/
FeJ and C57BL/6J.
Found at: doi:10.1371/journal.pgen.1000238.s004 (0.17 MB DOC)
Table S3 Sequencing primers for Atp2b2.
Found at: doi:10.1371/journal.pgen.1000238.s005 (0.07 MB DOC)
Text S1 Supplementary materials.
Found at: doi:10.1371/journal.pgen.1000238.s006 (0.05 MB DOC)
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